ERBB2 and breast cancer: In future studies concerning stage I-III and HoR+/HER2- breast cancer, we suggested that the age of 40 and 60 years are reasonable cutoff values to group the age in pre-menopausal patients diagnosed with breast cancer, and the age of 70 years are reasonable cutoff value to group the age in post-menopausal patients.